160 related articles for article (PubMed ID: 16503767)
21. The future of the new selective estrogen receptor modulators.
Palacios S
Menopause Int; 2007 Mar; 13(1):27-34. PubMed ID: 17448265
[TBL] [Abstract][Full Text] [Related]
22. Arzoxifene: the evidence for its development in the management of breast cancer.
Jackson LR; Cheung KL; Buzdar AU; Robertson JF
Core Evid; 2008 Jul; 2(4):251-8. PubMed ID: 21221190
[TBL] [Abstract][Full Text] [Related]
23. Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challenges.
Boisen MM; Andersen CL; Sreekumar S; Stern AM; Oesterreich S
Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():322-33. PubMed ID: 26276546
[TBL] [Abstract][Full Text] [Related]
24. Arzoxifene Eli Lilly.
Marchisano-Karpman C; DeGregorio MW
IDrugs; 2003 Sep; 6(9):880-5. PubMed ID: 12964068
[TBL] [Abstract][Full Text] [Related]
25. New selective estrogen receptor modulators (SERMs) in development.
Silverman SL
Curr Osteoporos Rep; 2010 Sep; 8(3):151-3. PubMed ID: 20603714
[TBL] [Abstract][Full Text] [Related]
26. Selective estrogen receptor modulators: an update on recent clinical findings.
Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
[TBL] [Abstract][Full Text] [Related]
27. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
Lewis JS; Jordan VC
Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
[TBL] [Abstract][Full Text] [Related]
28. Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer.
Xiong R; Zhao J; Gutgesell LM; Wang Y; Lee S; Karumudi B; Zhao H; Lu Y; Tonetti DA; Thatcher GR
J Med Chem; 2017 Feb; 60(4):1325-1342. PubMed ID: 28117994
[TBL] [Abstract][Full Text] [Related]
29. Effects of the new selective estrogen receptor modulator LY353381.HCl (Arzoxifene) on human endometrial cancer growth in athymic mice.
Dardes RC; Bentrem D; O'Regan RM; Schafer JM; Jordan VC
Clin Cancer Res; 2001 Dec; 7(12):4149-55. PubMed ID: 11751515
[TBL] [Abstract][Full Text] [Related]
30. A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer.
McMeekin DS; Gordon A; Fowler J; Melemed A; Buller R; Burke T; Bloss J; Sabbatini P
Gynecol Oncol; 2003 Jul; 90(1):64-9. PubMed ID: 12821343
[TBL] [Abstract][Full Text] [Related]
31. Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women.
Vogelvang TE; van der Mooren MJ; Mijatovic V; Kenemans P
Drugs; 2006; 66(2):191-221. PubMed ID: 16451093
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in selective estrogen receptor modulators for breast cancer.
Wang T; You Q; Huang FS; Xiang H
Mini Rev Med Chem; 2009 Sep; 9(10):1191-201. PubMed ID: 19817711
[TBL] [Abstract][Full Text] [Related]
33. Effect of the selective estrogen receptor modulator arzoxifene on repopulation of hormone-responsive breast cancer xenografts between courses of chemotherapy.
Wu L; Tannock IF
Clin Cancer Res; 2005 Nov; 11(22):8195-200. PubMed ID: 16299252
[TBL] [Abstract][Full Text] [Related]
34. Use of SERMs for treatment in postmenopausal women.
Pinkerton JV; Thomas S
J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794
[TBL] [Abstract][Full Text] [Related]
35. The selective estrogen receptor modulators in breast cancer prevention.
Li F; Dou J; Wei L; Li S; Liu J
Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
[TBL] [Abstract][Full Text] [Related]
36. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
Musa MA; Khan MO; Cooperwood JS
Curr Med Chem; 2007; 14(11):1249-61. PubMed ID: 17504144
[TBL] [Abstract][Full Text] [Related]
37. Selective estrogen-receptor modulators in 2001.
O'Regan RM; Gradishar WJ
Oncology (Williston Park); 2001 Sep; 15(9):1177-85, 1189-90; discussion 1190-4. PubMed ID: 11589065
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer chemoprevention: a review of selective estrogen receptor modulators.
Johansen AM
Clin J Oncol Nurs; 2005 Jun; 9(3):317-20. PubMed ID: 15973842
[TBL] [Abstract][Full Text] [Related]
39. [SERM--selective estrogen receptor modulators].
Kønig KB; Eiken PA; Schwarz P
Ugeskr Laeger; 2001 Apr; 163(15):2129-33. PubMed ID: 11332210
[TBL] [Abstract][Full Text] [Related]
40. Selective estrogen receptor modulators (SERMs): a review of clinical data.
Mirkin S; Pickar JH
Maturitas; 2015 Jan; 80(1):52-7. PubMed ID: 25466304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
